ESC Premium Access

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Congress Presentation

About the speaker

Professor Junichi Ishii

Fujita Health University Second Hospital, Nagoya (Japan)
0 follower

238 more presentations in this session

2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.

Speaker: Doctor D. Pol (Melbourne, AU)

Thumbnail

3D right ventricular ejection fraction and longitudinal strain are independent predictors of major adverse cardiovascular events in patients with rrhythmogenic right ventricular cardiomyopathy

Speaker: Assistant Professor L. Hosseini (Bojnurd, IR)

Thumbnail

A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves

Speaker: Doctor A. Snir (Sydney, AU)

Thumbnail

A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses

Speaker: Doctor T. Watanabe (Sendai, JP)

Thumbnail

A real-world comparison of outcomes between fractional flow reserve-guided versus angiography-guided percutaneous coronary intervention

Speaker: Doctor C. Wong (Sydney, AU)

Thumbnail

Access the full session

Abstract Programme

Speakers: Professor J. Ishii, Doctor D. Pol, Assistant Professor L. Hosseini, Doctor A. Snir, Doctor T. Watanabe...
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations